Repurposing of metabolic drugs and mitochondrial modulators as an emerging class of cancer therapeutics with a special focus on breast cancer

Repurposing of metabolic drugs and mitochondrial modulators as an emerging class of cancer therapeutics with a special focus on breast cancer

Background: As per facts sheet of WHO, cancer is a leading cause of mortality worldwide accounting nearly 10 million deaths in 2020. However, breast, lung, colon and rectum, prostate, skin and stomach cancers are the six most prevailing cancer across the globe. Out of the aforesaid cancers, breast c...

Full description

Bibliographic Details
Main Authors: Versha Tripathi, Pooja Jaiswal, Khageswar Sahu, Shovan Kumar Majumder, Dharmendra Kashyap, Hem Chandra Jha, Amit Kumar Dixit, Hamendra Singh Parmar
Format: Article
Language:English
Published: Elsevier 2022-12-01
Series:Advances in Cancer Biology - Metastasis
Subjects:
AICAR
Tigecycline
Cordycepin
Mitochondrial redox modulators
Statins
Fibrates
Online Access:http://www.sciencedirect.com/science/article/pii/S2667394022000399

Internet

http://www.sciencedirect.com/science/article/pii/S2667394022000399

Similar Items